These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19478384)

  • 1. A fast, sensitive and accurate high resolution melting (HRM) technology-based assay to screen for common K-ras mutations.
    Kramer D; Thunnissen FB; Gallegos-Ruiz MI; Smit EF; Postmus PE; Meijer CJ; Snijders PJ; Heideman DA
    Cell Oncol; 2009; 31(3):161-7. PubMed ID: 19478384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of high resolution melting (HRM) technology-based assays with direct sequencing possibility for effective mutation screening of EGFR and K-ras genes.
    Heideman DA; Thunnissen FB; Doeleman M; Kramer D; Verheul HM; Smit EF; Postmus PE; Meijer CJ; Meijer GA; Snijders PJ
    Cell Oncol; 2009; 31(5):329-33. PubMed ID: 19759413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.
    Do H; Krypuy M; Mitchell PL; Fox SB; Dobrovic A
    BMC Cancer; 2008 May; 8():142. PubMed ID: 18495026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA; Lurkin I; Doeleman M; Smit EF; Verheul HM; Meijer GA; Snijders PJ; Thunnissen E; Zwarthoff EC
    J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
    Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
    Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis.
    Fassina A; Gazziero A; Zardo D; Corradin M; Aldighieri E; Rossi GP
    J Clin Pathol; 2009 Dec; 62(12):1096-102. PubMed ID: 19640859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of PCR-HRM, RFLP, and direct sequencing as simple and cost-effective methods to detect common EGFR mutations in plasma cell-free DNA of non-small cell lung cancer patients.
    Zaini J; Syahruddin E; Yunus M; Andarini SL; Hudoyo A; Masykura N; Yasril R; Ridwanuloh A; Hidajat H; Nurwidya F; Suharsono S; Utomo ARH
    Cancer Rep (Hoboken); 2019 Aug; 2(4):e1159. PubMed ID: 32721094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of EGFR mutations in patients with non-small cell lung cancer by high resolution melting. Comparison with other methods.
    Martínez-Carretero C; Pascual FI; Rus A; Bernardo I
    Clin Chem Lab Med; 2017 Oct; 55(12):1970-1978. PubMed ID: 28432840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutation detection efficiency in EGFR: a comparison between high resolution melting analysis and Sanger sequencing.
    Joy RA; Thelakkattusserry SK; Vikkath N; Bhaskaran R; Krishnan S; Vasudevan D; Ariyannur PS
    BMC Cancer; 2020 Sep; 20(1):902. PubMed ID: 32962681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies.
    Do H; Dobrovic A
    Mol Cancer; 2009 Oct; 8():82. PubMed ID: 19811662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer.
    Sriram KB; Tan ME; Savarimuthu SM; Wright CM; Relan V; Stockwell RE; Clarke BE; Duhig EE; Yang IA; Bowman RV; Fong KM
    Eur Respir J; 2011 Oct; 38(4):903-10. PubMed ID: 21349912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High resolution melting analysis for epidermal growth factor receptor mutations in formalin-fixed paraffin-embedded tissue and plasma free DNA from non-small cell lung cancer patients.
    Jing CW; Wang Z; Cao HX; Ma R; Wu JZ
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6619-23. PubMed ID: 24377577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High resolution melting analysis for detecting p53 gene mutations in patients with non-small cell lung cancer].
    Chen Z; An S; Xie Z; Yan H; Chen J; Su J; Zhang X; Niu F; Guo W; Wu Y
    Zhongguo Fei Ai Za Zhi; 2011 Oct; 14(10):767-73. PubMed ID: 22008105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of KRAS mutations in colorectal cancer by high-resolution melting analysis.
    Ma ES; Wong CL; Law FB; Chan WK; Siu D
    J Clin Pathol; 2009 Oct; 62(10):886-91. PubMed ID: 19783717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR and K-ras mutation analysis in non-small cell lung cancer: comparison of paraffin embedded versus frozen specimens.
    Gallegos Ruiz MI; Floor K; Rijmen F; Grünberg K; Rodriguez JA; Giaccone G
    Cell Oncol; 2007; 29(3):257-64. PubMed ID: 17452778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening.
    Jänne PA; Borras AM; Kuang Y; Rogers AM; Joshi VA; Liyanage H; Lindeman N; Lee JC; Halmos B; Maher EA; Distel RJ; Meyerson M; Johnson BE
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):751-8. PubMed ID: 16467085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High resolution melting for mutation scanning of TP53 exons 5-8.
    Krypuy M; Ahmed AA; Etemadmoghadam D; Hyland SJ; ; DeFazio A; Fox SB; Brenton JD; Bowtell DD; Dobrovic A
    BMC Cancer; 2007 Aug; 7():168. PubMed ID: 17764544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct serum and tissue assay for EGFR mutation in non-small cell lung cancer by high-resolution melting analysis.
    Hu C; Liu X; Chen Y; Sun X; Gong Y; Geng M; Bi L
    Oncol Rep; 2012 Nov; 28(5):1815-21. PubMed ID: 22923193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors.
    Pichler M; Balic M; Stadelmeyer E; Ausch C; Wild M; Guelly C; Bauernhofer T; Samonigg H; Hoefler G; Dandachi N
    J Mol Diagn; 2009 Mar; 11(2):140-7. PubMed ID: 19213871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening of extended RAS mutations based on high-resolution melting analysis for prediction of anti-EGFR treatment efficacy in colorectal carcinoma.
    Ishige T; Itoga S; Sato K; Kitamura K; Nishimura M; Sawai S; Matsushita K; Suzuki K; Ota S; Miyauchi H; Matsubara H; Nakatani Y; Nomura F
    Clin Biochem; 2014 Dec; 47(18):340-3. PubMed ID: 25262986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.